PRIMO-25 (Methenolone Acetate) by Meditech is a pharmaceutical-grade oral anabolic-androgenic steroid formulated at 25 mg per tablet, supplied in sachets or blister packs of 50 tablets. Methenolone acetate is the oral acetate ester form of methenolone — a DHT-derived anabolic-androgenic compound with an established research history in comparative steroid pharmacology literature — distinguished from its injectable enanthate ester counterpart (Primobolan Depot) by its oral administration route and shorter-acting acetate ester, and distinguished from most other oral anabolic-androgenic steroids by its documented absence of 17α-alkylation, a structural characteristic of significant clinical relevance in comparative hepatotoxicity research.
 
✔ Key Research Insights
Studied for its DHT-derived pharmacological profile, including its documented absence of aromatization to estrogen, mild androgenic potency relative to anabolic activity, and non-17α-alkylated oral structure in comparative anabolic-androgenic steroid research
Investigated for its effects on lean mass preservation and protein synthesis parameters in research subjects across caloric deficit and recomposition protocols, with documented lean mass retention and minimal fluid accumulation referenced in comparative oral anabolic steroid literature
Researched for its comparatively reduced hepatotoxic profile relative to 17α-alkylated oral anabolic compounds, attributed to its non-alkylated structure — a pharmacologically distinct characteristic consistently noted in comparative oral anabolic steroid hepatotoxicity research
Examined for its influence on strength indices and endurance parameters in documented subject populations across anabolic research literature
Documented for its absence of estrogenic activity, with no aromatization to estrogen and no direct estrogenic receptor activity referenced in comparative steroid pharmacology research, associated with a consistently dry anabolic profile across research subject populations
Researched for its mild suppressive effects on the hypothalamic-pituitary-testicular axis relative to more potent anabolic-androgenic compounds in comparative endocrinological research literature
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: PRIMO-25
Molecule: Methenolone Acetate
Concentration: 25 mg per tablet
Appearance: Orange octagon-shaped tablet imprinted with logo "M"
Packing: 50 tablets per sachet or 50 tablets per blister pack
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
Methenolone acetate is a non-17α-alkylated DHT-derived anabolic-androgenic steroid administered orally via its acetate ester form. Unlike the majority of oral anabolic-androgenic steroids, which require 17α-alkylation to survive hepatic first-pass metabolism and achieve adequate oral bioavailability, methenolone acetate achieves partial oral bioavailability through its acetate ester modification without the introduction of a 17α-alkyl group — a structural distinction documented in comparative oral anabolic steroid hepatotoxicity research as contributing to a comparatively reduced hepatic stress profile. This non-alkylated oral bioavailability characteristic, while pharmacokinetically distinct from injectable methenolone enanthate, results in lower overall systemic bioavailability per unit dose relative to 17α-alkylated oral compounds, a pharmacokinetic consideration reflected in the higher milligram doses referenced in methenolone acetate research protocols relative to injectable preparations. Methenolone exerts its primary anabolic effects through androgen receptor binding in muscle tissue, with documented downstream influences on protein synthesis and nitrogen retention in research literature. Its DHT-derived structure confers complete resistance to aromatization via the aromatase enzyme, resulting in the documented absence of estrogenic effects including fluid retention across research subject populations. The mild androgenic profile and non-estrogenic anabolic activity of methenolone acetate have been documented across comparative steroid pharmacology research as producing lean, quality mass accrual with minimal water retention — consistent with the pharmacological characteristics of the methenolone compound class across both oral and injectable ester forms.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
Non-17α-alkylated oral anabolic formulation with a comparatively reduced hepatotoxic profile relative to alkylated oral anabolic-androgenic steroids, as documented in comparative steroid hepatotoxicity research literature
DHT-derived compound with a well-documented absence of aromatization and mild androgenic profile referenced consistently across comparative anabolic-androgenic steroid pharmacology research
Distinctively identified orange octagon tablet presentation at 25 mg per tablet for consistent product recognition
Available in both sachet and blister pack formats providing 50 tablets per unit
Widely referenced in anabolic pharmacology research under the methenolone acetate and oral Primobolan designations